Here’s a spoiler alert. I like vaccinations.

Two of my friends growing up, one with mean leg braces and the other confined to a wheelchair, were polio victims. I’ll be celebrating World Polio Day on Oct . 24, and I was happy to learn that we’ve achieved a 99.9 percent worldwide reduction in polio cases over the past three decades. The area preventing total eradication of polio — the wild poliovirus areas of Afghanistan and Pakistan.

Then there is sub-Saharan Africa where a half million people, mostly children, die each year from Malaria where the new RTS S Malaria
Continue Reading Letter From The Editor: Leadership & vaccination resistance

Dr. Stephen Hahn, a chief medical executive at the University of Texas MD Anderson Cancer Center in Houston, likely will be the next Food and Drug Administration (FDA), Commissioner.

President Donald J. Trump has nominated Dr. Hahn to be the next FDA Commissioner, and U.S.Senate will likely, eventually, confirm the nomination.

Sen. Lamar Alexander, R-TN, said he is looking forward to meeting with Hahn and scheduling his confirmation hearing. Alexander chairs the Senate Health, Education, Labor, and Pensions (HELP) Committee.

Senator Patty Murray, D-WA, is the ranking member of the HELP Committee. She and other Democrats are going to have
Continue Reading A top cancer expert in line to be next FDA commissioner

The Wall Street Journal’s May 22 Health Forum at the Four Seasons Hotel in Washington D.C. will feature 22 speakers, including several CEOs for big pharmacy and giant insurance companies.

But in a full-page advertisement, which WSJ has been running at the expense of its paper and ink, the top billing goes to Food and Drug Administration Commissioner Scott Gottlieb.

Scott Gottlieb

Gottlieb will complete his first year as FDA Commissioner on May 11. He returned a year ago to head FDA, where he’d earlier served as deputy commissioner for Medical and Scientific Affairs. The
Continue Reading Scott Gottlieb keeps FDA office hours while growing star power

It was an hour and 57 minutes into the confirmation hearing for the next Food and Drug Administration commissioner before Scott Gottlieb drew a question about food.

Perhaps to be expected, it came from Sen. Pat Roberts, R-KS, who wanted to know if Gottlieb would favor setting some priorities for enforcement of the Food Safety Modernization Act (FSMA) and coordinate with the U.S. Department of Agriculture so that changes to nutrition labeling could occur at approximately the same time.

Roberts chairs the Senate Agriculture Committee.

Scott Gottlieb
Scott Gottlieb

Sen. Lisa Murkowski, R-AK, also had some questions about
Continue Reading Only a handful of food questions during Gottlieb’s FDA hearing

The Senate Committee on Health, Education, Labor and Pensions, also known as the HELP Committee, will conduct a confirmation hearing next Wednesday for Dr. Scott Gottlieb to serve as commissioner of the Food and Drug Administration.

The way was cleared for the hearing when Gottlieb submitted all required paperwork to the Office of Government Ethics. In the filings, Gottlieb reportedly outlines how he will realign his finances to eliminate ties he has had with the pharmaceutical industry if he is confirmed as its chief regulator.

Scott Gottlieb
Scott Gottlieb

This realignment will include resigning from boards and consulting
Continue Reading Confirmation hearing for FDA Commissioner set for April 5

Scott Gottlieb, a practicing physician and resident fellow at the American Enterprise Institute, is President Donald J. Trump’s pick to be the 23rd commissioner of the Food and Drug Administration.

He was FDA’s deputy commissioners for medical and scientific affairs from 2005 to 2007.

Gottlieb_406x250Dr. Gottlieb is one of the nation’s foremost voices for “changing the FDA’s culture.” His views on issues are easy enough to find as he’s been putting them out there for AEI and in national periodicals for the past decade.

“The FDA’s cumbersome (drug) approval process has been a long time in the making, but its
Continue Reading President Trump Picks Scott Gottlieb as Next FDA Commissioner

While the Secretary of Health and Human Services Tom Price says we can expect the next Food and Drug Administrator commissioner to be named soon, significant meetings held by designated FDA policy makers with persons outside the executive branch continue to draw down.

Acting FDA Commissioner Stephen M. Ostroff has so far reported on three meetings with outsiders during February. He met Feb. 10 with Martin Slayne, global head of scientific and regulatory affairs, and five others from the Hershey Co.

yearOFrooster_406x250And on Feb. 15, enough produce growers from throughout North America descended upon FDA headquarters in College Park, MD,
Continue Reading Vacant positions are slowing things down at FDA and FSIS